Nathan J. Dowden

President & COO at Entrada Therapeutics · 4 reported transactions in 1 company · latest report Mar 3, 2026

Their trades


Entrada TherapeuticsTRDA	Shares withheld for tax $165K · 14,038 shares	Mar 3, 2026
Entrada TherapeuticsTRDA	Shares withheld for tax $84.2K · 7,223 shares	Mar 2, 2026
Entrada TherapeuticsTRDA	Share award — · 55,800 shares	Mar 1, 2026
Entrada TherapeuticsTRDA	Shares withheld for tax $9.5K · 1,746 shares	Sep 2, 2025

Shares withheld for taxEntrada Therapeutics

Mar 3, 2026 · TRDA

$165K

Shares withheld for taxEntrada Therapeutics

Mar 2, 2026 · TRDA

$84.2K

Mar 1, 2026 · TRDA

55,800

Shares withheld for taxEntrada Therapeutics

Sep 2, 2025 · TRDA

$9.5K

4 transactionsPro adds every trade with how it did, their holdings and the money-flow chartPro is $29 a month

Built from their public trade reports and market prices: past moves, not predictions or advice.

President & COO at Entrada Therapeutics · 4 reported transactions in 1 company · latest report Mar 3, 2026


Entrada TherapeuticsTRDA	Shares withheld for tax $165K · 14,038 shares	Mar 3, 2026
Entrada TherapeuticsTRDA	Shares withheld for tax $84.2K · 7,223 shares	Mar 2, 2026
Entrada TherapeuticsTRDA	Share award — · 55,800 shares	Mar 1, 2026
Entrada TherapeuticsTRDA	Shares withheld for tax $9.5K · 1,746 shares	Sep 2, 2025

Shares withheld for taxEntrada Therapeutics

Mar 3, 2026 · TRDA

$165K

Shares withheld for taxEntrada Therapeutics

Mar 2, 2026 · TRDA

$84.2K

Mar 1, 2026 · TRDA

55,800

Shares withheld for taxEntrada Therapeutics

Sep 2, 2025 · TRDA

$9.5K

4 transactionsPro adds every trade with how it did, their holdings and the money-flow chartPro is $29 a month

Built from their public trade reports and market prices: past moves, not predictions or advice.